MedTrace Logo

Managing Breast Cancer Treatment: Dyad's Perspectives on Treatment Decision, Financial and Family Burden.

NCT05917444 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 224

Last updated 2023-06-23

No results posted yet for this study

Summary

The purpose of this study is to understand the financial burden and treatment decisions, based on both of patient's and family's perspectives in breast cancer patients who receive systemic chemotherapy, targeted therapy or immuno-therapy and their family caregivers .

Conditions

Sponsors & Collaborators

  • National Taipei University of Nursing and Health Sciences

    collaborator OTHER

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Yen-Shen Lu · National Taiwan University Hospital

  • Shiuyu C. LEe · National Taipei University of Nursing and Health Science

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-12
Primary Completion
2025-03-31
Completion
2025-03-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05917444 on ClinicalTrials.gov